Viyash Scientific Ltd (VIYASH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 213056,
    "name": "Viyash Scientifi",
    "stock_name": "Viyash Scientifi",
    "full_name": "Viyash Scientific Ltd",
    "name_url": "stocks-analysis/viyash-scientifi",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "212.30",
    "chg": 8.7,
    "chgp": "4.27%",
    "dir": 1,
    "prev_price": "203.60",
    "mcapval": "9,269.40 Cr",
    "mcap": "Small Cap",
    "scripcode": 512529,
    "symbol": "VIYASH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE807F01027",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "13.87 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/viyash-scientifi-213056-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://uat-researchintel.adityabirlamoney.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/viyash-scientifi-213056-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Sequent Scientific Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-technical-momentum-shifts-amid-mixed-market-signals-3742737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SequentScientif_technicaldot_3742737.png",
        "date": "2025-12-03 08:01:54",
        "description": "Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a strongly bullish stance to a more tempered mildly bullish outlook, underscoring the importance of closely monitoring technical indicators such as MACD, RSI, moving averages, and other momentum oscillators."
      },
      {
        "title": "Is Sequent Scien. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sequent-scien-overvalued-or-undervalued-3739814",
        "imagepath": "",
        "date": "2025-12-02 08:08:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Understanding Sequent Scientific’s Valuation Metrics</strong></p>\n<p>Sequent Scientific currently trades at a price of ₹221.25, having seen a 52-week range between ₹111.00 and ₹260.30. The company’s price-to-earnings (PE) ratio stands at a striking 126.16, which is considerably higher than typical industry averages. This elevated PE ratio often signals high growth expectations priced into the stock. However, the price-to-book value of 6.92 and enterprise value to EBITDA (EV/EBITDA) ratio of 31.90 indicate that while the stock is priced richly, it is not excessively so when compared to its earnings before interest, taxes, depreciation, and amortisation.</p>\n<p>Return on capital employed (ROCE) at 10.17% and return on equity (ROE) at 5.48% reflect moderate profitability levels. These returns, ..."
      },
      {
        "title": "Sequent Scien. Sees Revision in Market Assessment Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sequent-scien-upgraded-from-sell-to-hold-by-marketsmojo-on-2-sep-2025-3735288",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScien_mojoScore_3735288.png",
        "date": "2025-11-28 10:04:56",
        "description": "Sequent Scien., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation. This shift reflects a nuanced view of the company’s financial and technical parameters, highlighting both promising trends and ongoing challenges within its operational and valuation metrics."
      },
      {
        "title": "Why is Sequent Scien. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sequent-scien-fallingrising-3726601",
        "imagepath": "",
        "date": "2025-11-25 00:29:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Behaviour</strong></p>\n<p>Sequent Scientific’s shares have been under pressure for the last three consecutive days, cumulatively losing nearly 11.93% in value. On the day in question, the stock underperformed its sector by 6.65%, touching an intraday low of ₹221.10, which represents a 7.32% decline from previous levels. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure. Additionally, the stock experienced significant intraday volatility of 5.24%, reflecting uncertainty among traders and investors.</p>\n<p>Technical indicators reveal that while the stock price remains above its 50-day, 100-day, and 200-day moving averages, it is currently trading below its 5-day and 20-day moving ..."
      },
      {
        "title": "Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-hits-intraday-low-amid-price-pressure-on-24-nov-2025-3725847",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScientif_priceRelatedfactors_3725847.png",
        "date": "2025-11-24 15:15:53",
        "description": "Sequent Scientific experienced notable intraday weakness on 24 Nov 2025, touching a low of Rs 221.1 as the stock faced significant price pressure. The decline occurred amid broader market volatility, with the Sensex reversing sharply after a positive start to the day."
      },
      {
        "title": "Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-hits-intraday-low-amid-price-pressure-on-20-nov-2025-3718476",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScientif_priceRelatedfactors_3718476.png",
        "date": "2025-11-20 15:46:24",
        "description": "Sequent Scientific experienced a notable intraday decline on 20 Nov 2025, touching a low of Rs 234, reflecting a price pressure of 7.12% during the trading session. This movement contrasts with the broader market trend, where the Sensex recorded gains and reached a new 52-week high."
      },
      {
        "title": "Sequent Scientific Hits New 52-Week High at Rs.260.3 Mark",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-hits-new-52-week-high-at-rs2603-3714985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScientif_priceRelatedfactors_3714985.png",
        "date": "2025-11-19 09:43:59",
        "description": "Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.260.3 today, marking a significant milestone in its stock performance. This peak reflects the stock’s sustained momentum over the past year amid a broader market environment showing cautious optimism."
      },
      {
        "title": "Why is Sequent Scien. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sequent-scien-fallingrising-3712855",
        "imagepath": "",
        "date": "2025-11-18 21:51:52",
        "description": "As of 18-Nov, Sequent Scientific Ltd is experiencing a price increase, currently at Rs. 247.65, reflecting a rise of 16.3 points or 7.05%. The stock has recently hit a new 52-week high of Rs. 249.5 and has shown strong performance today, outperforming its sector by 7.67%. Over the past week, the stock has gained 8.29%, and it has delivered a remarkable 22.03% return over the last month. The company has reported a significant growth in net profit of 209.15% and has declared positive results for the last seven consecutive quarters, contributing to investor confidence. Additionally, the stock's moving averages indicate it is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting a strong upward trend.\n\nIn the broader market context, Sequent Scientific's short-term performance has significantly outpaced the benchmark, with a 1-week return of 8.29% compared to the Sensex's 0.96%..."
      },
      {
        "title": "Sequent Scientific Hits Intraday High with Strong 7.2% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-hits-intraday-high-with-72-surge-on-18-nov-2025-3712124",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScientif_priceRelatedfactors_3712124.png",
        "date": "2025-11-18 15:07:04",
        "description": "Sequent Scientific recorded a robust intraday performance today, surging to a new 52-week high of Rs.249.15, marking a 7.69% rise during the trading session. This notable uptick outpaced the Pharmaceuticals & Biotechnology sector and the broader market, reflecting significant trading momentum."
      }
    ],
    "total": 217,
    "sid": "213056",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/viyash-scientific-213056"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "29-Jan-2026",
      "details": "Allotment of ESOP",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "22-Jan-2026",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "21-Jan-2026",
      "details": "Company has scheduled a conference call with the Analysts/Investors on Friday February 06 2026 at 9.00 a.m. (I.S.T.) to discuss its Q3FY26 financial results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Viyash Scientific Ltd has declared <strong>25%</strong> dividend, ex-date: 08 Sep 21",
          "dt": "2021-09-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Viyash Scientific Ltd has announced <strong>2:10</strong> stock split, ex-date: 25 Feb 16",
          "dt": "2016-02-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sequent Scientific Technical Momentum Shifts Amid Mixed Market Signals

2025-12-03 08:01:54

Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a strongly bullish stance to a more tempered mildly bullish outlook, underscoring the importance of closely monitoring technical indicators such as MACD, RSI, moving averages, and other momentum oscillators.

Is Sequent Scien. overvalued or undervalued?

2025-12-02 08:08:12

Understanding Sequent Scientific’s Valuation Metrics Sequent Scientific currently trades at a price of ₹221.25, having seen a 52-week range between ₹111.00 and ₹260.30. The company’s price-to-earnings (PE) ratio stands at a striking 126.16, which is considerably higher than typical industry averages. This elevated PE ratio often signals high growth expectations priced into the stock. However, the price-to-book value of 6.92 and enterprise value to EBITDA (EV/EBITDA) ratio of 31.90 indicate that while the stock is priced richly, it is not excessively so when compared to its earnings before interest, taxes, depreciation, and amortisation. Return on capital employed (ROCE) at 10.17% and return on equity (ROE) at 5.48% reflect moderate profitability levels. These returns, ...

Sequent Scien. Sees Revision in Market Assessment Amid Mixed Financial Signals

2025-11-28 10:04:56

Sequent Scien., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation. This shift reflects a nuanced view of the company’s financial and technical parameters, highlighting both promising trends and ongoing challenges within its operational and valuation metrics.

Why is Sequent Scien. falling/rising?

2025-11-25 00:29:04

Short-Term Price Movement and Market Behaviour Sequent Scientific’s shares have been under pressure for the last three consecutive days, cumulatively losing nearly 11.93% in value. On the day in question, the stock underperformed its sector by 6.65%, touching an intraday low of ₹221.10, which represents a 7.32% decline from previous levels. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure. Additionally, the stock experienced significant intraday volatility of 5.24%, reflecting uncertainty among traders and investors. Technical indicators reveal that while the stock price remains above its 50-day, 100-day, and 200-day moving averages, it is currently trading below its 5-day and 20-day moving ...

Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Volatility

2025-11-24 15:15:53

Sequent Scientific experienced notable intraday weakness on 24 Nov 2025, touching a low of Rs 221.1 as the stock faced significant price pressure. The decline occurred amid broader market volatility, with the Sensex reversing sharply after a positive start to the day.

Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Sentiment

2025-11-20 15:46:24

Sequent Scientific experienced a notable intraday decline on 20 Nov 2025, touching a low of Rs 234, reflecting a price pressure of 7.12% during the trading session. This movement contrasts with the broader market trend, where the Sensex recorded gains and reached a new 52-week high.

Sequent Scientific Hits New 52-Week High at Rs.260.3 Mark

2025-11-19 09:43:59

Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.260.3 today, marking a significant milestone in its stock performance. This peak reflects the stock’s sustained momentum over the past year amid a broader market environment showing cautious optimism.

Why is Sequent Scien. falling/rising?

2025-11-18 21:51:52

As of 18-Nov, Sequent Scientific Ltd is experiencing a price increase, currently at Rs. 247.65, reflecting a rise of 16.3 points or 7.05%. The stock has recently hit a new 52-week high of Rs. 249.5 and has shown strong performance today, outperforming its sector by 7.67%. Over the past week, the stock has gained 8.29%, and it has delivered a remarkable 22.03% return over the last month. The company has reported a significant growth in net profit of 209.15% and has declared positive results for the last seven consecutive quarters, contributing to investor confidence. Additionally, the stock's moving averages indicate it is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting a strong upward trend. In the broader market context, Sequent Scientific's short-term performance has significantly outpaced the benchmark, with a 1-week return of 8.29% compared to the Sensex's 0.96%...

Sequent Scientific Hits Intraday High with Strong 7.2% Surge

2025-11-18 15:07:04

Sequent Scientific recorded a robust intraday performance today, surging to a new 52-week high of Rs.249.15, marking a 7.69% rise during the trading session. This notable uptick outpaced the Pharmaceuticals & Biotechnology sector and the broader market, reflecting significant trading momentum.

View All News